Clinical Trials Logo

Thyroid Eye Disease clinical trials

View clinical trials related to Thyroid Eye Disease.

Filter by:

NCT ID: NCT01297699 Completed - Thyroid Eye Disease Clinical Trials

Tocilizumab Treatment in Graves´ Ophthalmopathy (Graves´ Orbitopathy or Thyroid Eye Disease)

GRC
Start date: March 2012
Phase: Phase 3
Study type: Interventional

The purpose is to investigate tocilizumab administration in patients with moderately to severely or sight-threatening GO (Graves' ophthalmopathy) without response to treatment with corticoid intravenous pulses. Currently, these patients only have surgery as therapeutic alternative. The principal aim of this study is to evaluate efficacy and safety of tocilizumab treatment in order to provide a better alternative to surgery for this patients.